{
  "meta": {
    "title": "Parasitology",
    "url": "https://brainandscalpel.vercel.app/parasitology-115fa4e6.html",
    "scrapedAt": "2025-12-01T04:08:04.965Z"
  },
  "questions": [
    {
      "text": "<p>A 45-year-old previously healthy woman comes to the emergency department due to 2 days of fever, chills, malaise, and fatigue.&nbsp; The patient returned from a wildlife safari in Africa 3 weeks ago.&nbsp; She took mefloquine for malaria prophylaxis during the trip.&nbsp; She was advised to continue the medication for 4 weeks after return but stopped taking it upon arrival in the United States.&nbsp; Peripheral blood smear shows <em>Plasmodium falciparum</em>.&nbsp; Inactivity of the medication against which of the following best explains this patient&#39;s symptoms?</p>",
      "choices": [
        {
          "id": 1,
          "text": "Chloroquine-resistant strains"
        },
        {
          "id": 2,
          "text": "Circulating gametocytes"
        },
        {
          "id": 3,
          "text": "Dormant liver hypnozoites"
        },
        {
          "id": 4,
          "text": "Exoerythrocytic tissue schizonts"
        },
        {
          "id": 5,
          "text": "Intraerythrocytic trophozoites"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<div style='margin-bottom:10px; font-size:0.85em; opacity:0.7;'>Microbiology > Microbiology (General Principles) > Malaria</div><hr style='border-color:rgba(255,255,255,0.1); margin:10px 0;'><p><img  draggable=\"false\" id=\"2934\" src=\"https://www.uworld.com/media/highresdefault/L25881.jpg\"  ></p><p>Travelers to <a href=\"877\">malaria-endemic regions</a> should be counseled on mosquito avoidance measures and given chemoprophylaxis.&nbsp; <strong>Mosquito avoidance</strong> strategies include staying indoors at dawn and dusk (when mosquitoes are most active), wearing insect repellant, limiting exposed skin, and sleeping within insecticide-treated nets.&nbsp; <strong>Chemoprophylaxis</strong> targets the predominant species of the region and takes into account the presence of drug resistance.&nbsp; In Africa, where chloroquine-resistant <em>Plasmodium falciparum</em> is endemic, common chemoprophylaxis regimens include atovaquone-proguanil, doxycycline, and mefloquine.</p><p><strong>Mefloquine</strong> is a schizonticide that actively <strong>destroys replicating parasites</strong> within red blood cells.&nbsp; However, it is inactivated in the liver and has <strong>no efficacy against hepatic</strong> (exoerythrocytic tissue) <strong>schizonts</strong>.&nbsp; Because <em>P falciparum</em> schizonts mature in the liver over <strong>8-30 days</strong>, travelers must take mefloquine chemoprophylaxis for <strong>4 weeks upon returning</strong> from malaria-endemic areas to ensure that schizonts released from the liver are destroyed when they infect red blood cells.&nbsp; Individuals who do not take mefloquine upon return (as in this case) can develop intraerythrocytic infection, leading to symptomatic malaria.</p><p><strong>(Choice A)</strong>&nbsp; In Africa, <em>P falciparum</em> is usually resistant to chloroquine.&nbsp; Therefore, alternate agents (eg, mefloquine) are given for chemoprophylaxis.&nbsp; Cross-resistance between classes of medications does not typically occur.</p><p><strong>(Choice B)</strong>&nbsp; Malaria parasites undergo asexual reproduction in humans.&nbsp; However, a minority of circulating merozoites differentiate into male and female gametocytes that can be passed to feeding <em>Anopheles</em> mosquitoes to continue their replicative cycle (malaria parasites undergo sexual reproduction in the midgut of the mosquito).&nbsp; Gametocytes do not undergo sexual reproduction in humans and do not cause symptoms.</p><p><strong>(Choice C)</strong>&nbsp; <em>Plasmodium ovale</em> and <em>Plasmodium vivax</em> have a dormant hepatic phase (hypnozoite) that may reactivate several months after a human host returns from a malaria-endemic region (if not treated with primaquine).&nbsp; In contrast, <em>P falciparum</em> does not have a dormant hepatic phase; it matures in (and is released from) the liver over 8-30 days.</p><p><strong>(Choice E)</strong>&nbsp; Mefloquine has strong activity against intraerythrocytic <em>Plasmodium</em> trophozoites.&nbsp; Furthermore, intraerythrocytic trophozoites typically lyse red blood cells every 24-48 hours, leading to cyclic symptoms (eg, fever, chills, malaise); it is unlikely that an intraerythrocytic infection would cause symptoms several weeks later.</p><p><strong>Educational objective:</strong><br>Mefloquine chemoprophylaxis for malaria must be continued for 4 weeks after return from a malaria-endemic region to ensure the elimination of hepatic schizonts (which mature in the liver over 8-30 days).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "14050",
      "difficulty": "N/A"
    }
  ]
}